P

Inventor

DAWSON VALINA L

US11 patents
⚠️ This page may combine multiple inventors who share the name “DAWSON VALINA L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV JOHNS HOPKINS

5 patents
US5587384ADec 24, 1996

Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

UNIV JOHNS HOPKINS109 citations97
USRE36397ENov 16, 1999

Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

UNIV JOHNS HOPKINS87 citations95
US6358975B1Mar 19, 2002

Method of using selective parp inhibitors to prevent or treat neurotoxicity

UNIV JOHNS HOPKINS43 citations86
US12233109B2Feb 25, 2025

Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative conditions

UNIV JOHNS HOPKINS0 citations57
US11123405B2Sep 21, 2021

Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditions

UNIV JOHNS HOPKINS0 citations57

DAWSON TED M

2 patents
US8603994B2Dec 10, 2013

Transcriptional repression leading to Parkinson's disease

DAWSON TED M3 citations56
US9623039B2Apr 18, 2017

Treatment and prevention of pathological conditions using iduna related techniques and compositions

DAWSON TED M0 citations43

VALTED LLC

2 patents
US9274128B2Mar 1, 2016

Transcriptional repression leading to parkinson's disease

VALTED LLC0 citations44
US8921042B2Dec 30, 2014

Transcriptional repression leading to Parkinson's disease

VALTED LLC0 citations44

DAWSON VALINA L

1 patent
US5266594ANov 30, 1993

Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity

DAWSON VALINA L65 citations92

UNIV JOHNS HOPKINS MED

1 patent
US6362160B1Mar 26, 2002

Immunophilin-binding agents prevent glutamate neurotoxicity associated with vascular stroke and neurodegenerative diseases

UNIV JOHNS HOPKINS MED14 citations83